Candriam SCA’s Chimerix, Inc. CMRX Stock Holding History

Candriam SCA’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-68,000	Closed	-$3.14M	–	649
2015 Q2	$3.14M	Buy	68,000 +3,000	+5%	+$120K	0.07%	307
2015 Q1	$2.45M	Buy	65,000 +25,000	+63%	+$992K	0.05%	359
2014 Q4	$1.61M	Buy	+40,000	New	+$1.35M	0.03%	388

Other funds holding CMRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Candriam SCA's CMRX Position: Q3 2015 in Review

Candriam SCA sold out of Chimerix, Inc. (CMRX) in Q3 2015, closing a stake of 68,000 shares — an estimated $3.14M sold.

Candriam SCA first reported a position in CMRX in Q4 2014 and held it in 3 quarters. The position peaked at $3.14M in Q2 2015. 156 funds tracked by Wall St. Rank hold CMRX as of Q3 2015.

Candriam SCA reported no remaining Chimerix, Inc. position as of Q3 2015 after selling out during the quarter.
Candriam SCA sold 68,000 Chimerix, Inc. shares in Q3 2015, an estimated $3.14M.
Candriam SCA first reported a position in Chimerix, Inc. in Q4 2014 and held it in 3 quarters.
Candriam SCA's Chimerix, Inc. position peaked at $3.14M in Q2 2015.
156 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2015.

Based on Candriam SCA's 13F filing for Q3 2015, filed 19 Oct 2015.